BCL9L | OmnibusX

Name	Number of supported studies	Average coverage
epithelial cell	4 studies	23% ± 7%	Explore
natural killer cell	3 studies	21% ± 5%	Explore
CD16-positive, CD56-dim natural killer cell, human	3 studies	28% ± 12%	Explore
CD8-positive, alpha-beta T cell	3 studies	24% ± 6%	Explore
effector memory CD8-positive, alpha-beta T cell	3 studies	31% ± 8%	Explore
ciliated cell	3 studies	25% ± 9%	Explore

sc-RNAseq data

Insufficient scRNA-seq data for expression of BCL9L at tissue level.

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	4929.08	1444 / 1445	100%	39.44	183 / 183
ovary	100%	6084.98	180 / 180	99%	36.50	427 / 430
stomach	100%	3219.38	358 / 359	97%	23.60	278 / 286
lung	100%	5482.11	578 / 578	97%	25.72	1115 / 1155
intestine	100%	4223.74	965 / 966	96%	18.26	507 / 527
breast	100%	4668.47	459 / 459	96%	22.09	1068 / 1118
pancreas	99%	2243.23	325 / 328	96%	21.64	170 / 178
skin	100%	6976.58	1809 / 1809	94%	17.71	444 / 472
bladder	100%	4934.76	21 / 21	90%	14.77	454 / 504
prostate	100%	4098.52	245 / 245	88%	13.95	442 / 502
uterus	100%	6514.28	170 / 170	87%	15.67	398 / 459
thymus	100%	3734.40	650 / 653	86%	11.62	518 / 605
kidney	98%	2337.46	87 / 89	86%	13.67	777 / 901
brain	71%	1545.99	1872 / 2642	93%	14.00	659 / 705
adrenal gland	100%	5198.15	258 / 258	64%	5.85	147 / 230
liver	82%	1135.57	185 / 226	53%	7.13	216 / 406
spleen	100%	2820.46	241 / 241	0%	0	0 / 0
blood vessel	100%	6577.31	1334 / 1335	0%	0	0 / 0
adipose	100%	4582.34	1203 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	98%	17.97	78 / 80
muscle	97%	3253.37	782 / 803	0%	0	0 / 0
heart	94%	3003.37	810 / 861	0%	0	0 / 0
tonsil	0%	0	0 / 0	91%	14.80	41 / 45
lymph node	0%	0	0 / 0	59%	7.65	17 / 29
peripheral blood	58%	1111.79	535 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

GO_0022604	Biological process	regulation of cell morphogenesis
GO_0010718	Biological process	positive regulation of epithelial to mesenchymal transition
GO_0006366	Biological process	transcription by RNA polymerase II
GO_0035914	Biological process	skeletal muscle cell differentiation
GO_0030512	Biological process	negative regulation of transforming growth factor beta receptor signaling pathway
GO_0035019	Biological process	somatic stem cell population maintenance
GO_0045445	Biological process	myoblast differentiation
GO_0060070	Biological process	canonical Wnt signaling pathway
GO_0045944	Biological process	positive regulation of transcription by RNA polymerase II
GO_1990907	Cellular component	beta-catenin-TCF complex
GO_0005654	Cellular component	nucleoplasm
GO_0001650	Cellular component	fibrillar center
GO_0005634	Cellular component	nucleus
GO_0003713	Molecular function	transcription coactivator activity
GO_0008013	Molecular function	beta-catenin binding

Gene name	BCL9L
Protein name	BCL9 like B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2)
Synonyms	DLNB11
Description	FUNCTION: Transcriptional regulator that acts as an activator. Promotes beta-catenin transcriptional activity. Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1 (By similarity). .
Accessions	A0A087WZX0 ENST00000683865.1 [Q86UU0-1] Q86UU0 ENST00000334801.7 [Q86UU0-1] ENST00000526143.2

BCL9L report